#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA5039228	F	Antiviral activity against wild type Rhinovirus-A02 infected in HeLa cells assessed as reduction in virus-induced cytopathic effect incubated for 3 days by MTS/PMS assay	Rhinovirus	4	ALA5038578	cell-based format	Scientific Literature
2.	ALA5039229	F	Antiviral activity against wild type Human rhinovirus B14 infected in HeLa cells assessed as reduction in virus-induced cytopathic effect incubated for 3 days by MTS/PMS assay	rhinovirus B14	4	ALA5038578	organism-based format	Scientific Literature
3.	ALA5039230	B	Inhibition of Human enterovirus 71 3C-like protease expressed in Escherichia coli BL21 (DE3) cells using Dacyl-KTSAVLQSGFRKMEEdans as fluorogenic substrate incubated for 10 mins by FRET assay	Enterovirus A71	24	ALA5038578	cell-based format	Scientific Literature
4.	ALA5039231	F	Antiviral activity against Human enterovirus 71 BrCr infected in human RD cells assessed as reduction in virus-induced cytopathic effect incubated for 4 days by MTS/PMS assay	Enterovirus A71	24	ALA5038578	organism-based format	Scientific Literature
5.	ALA5039232	T	Cytotoxicity against human RD cells assessed as reduction in cell viability measured after 4 days by MTS/PMS assay	Homo sapiens	24	ALA5038578	cell-based format	Scientific Literature
6.	ALA5039233	F	Antiviral activity against Human enterovirus 68 infected in HeLa cells assessed as reduction in virus-induced cytopathic effect incubated for 4 days by MTS/PMS assay	enterovirus D68	4	ALA5038578	organism-based format	Scientific Literature
7.	ALA5039234	F	Antiviral activity against Human coxsackievirus A21 infected in HeLa cells assessed as reduction in virus-induced cytopathic effect incubated for 3 days by MTS/PMS assay	Coxsackievirus A21	4	ALA5038578	organism-based format	Scientific Literature
8.	ALA5039235	F	Antiviral activity against Human coxsackievirus B3 infected in Vero cells assessed as reduction in plaque formation treated 2 hrs post viral infection and measured 3 to 4 days post-infection by Giemsa staining based plaque reduction assay	Coxsackievirus B3	4	ALA5038578	organism-based format	Scientific Literature
9.	ALA5039255	B	Inhibition of SARS-CoV2 3C-like protease expressed in Escherichia coli BL21 (DE3) cells using Mca-AVLQSGFR-Lys(Dnp)-Lys-NH2 as fluorogenic substrate incubated for 10 mins by FRET assay	Severe acute respiratory syndrome coronavirus 2	13	ALA5038578	cell-based format	Scientific Literature
10.	ALA5039256	F	Antiviral activity against SARS Cov-2 infected in Vero E6 cells assessed as reduction in viral RNA replication measured 24 hrs post infection by qRT-PCR analysis	Severe acute respiratory syndrome coronavirus 2	13	ALA5038578	organism-based format	Scientific Literature
11.	ALA5039257	T	Cytotoxicity against African green monkey Vero E6 cells assessed as reduction in cell viability incubated for 24 hrs by CCK8 assay	Chlorocebus sabaeus	13	ALA5038578	cell-based format	Scientific Literature